Enhanced Pan-Antiallergy Vaccine System

An improved pan-antiallergy vaccine system that enhances the immune response, monitors allergy symptoms, and adjusts vaccine dosage accordingly, providing a safer and more efficient treatment for allergies.

The original pan-antiallergy vaccine patent has limitations in terms of dosage adjustment and immune response enhancement. The new inventive concept addresses these limitations by introducing a wearable device and a computer program to monitor allergy symptoms and adjust vaccine dosage, as well as novel adjuvant compositions and modified protein constructs to enhance the immune response.

The enhanced pan-antiallergy vaccine system comprises a wearable device that continuously monitors a user's allergy symptoms, transmitting data to a computer program that adjusts the vaccine dosage accordingly. The system also includes novel adjuvant compositions that increase the production of IgE-neutralizing antibodies, and modified protein constructs with linker peptides that enhance the binding affinity to IgE. Additionally, the system includes a composition for treating allergies that combines the pan-antiallergy vaccine with a secondary medication that inhibits the release of histamine from mast cells.

The new claims introduce novel and non-obvious features, including the wearable device and computer program for dosage adjustment, novel adjuvant compositions, and modified protein constructs with linker peptides. These features provide a significant improvement over the original patent, enhancing the immune response, safety, and efficiency of the pan-antiallergy vaccine.

Alternative embodiments of the inventive concept could include different wearable device designs, alternative adjuvant compositions, and varying linker peptides in the modified protein constructs. Variations could also include different secondary medications for treating allergies, and integrating the system with electronic health records for more accurate patient profiling.

The enhanced pan-antiallergy vaccine system has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the treatment of allergies and asthma. The system's ability to monitor and adjust vaccine dosage in real-time, combined with its enhanced immune response and safety features, make it an attractive solution for patients and healthcare providers alike.